#	Pagina
attuale pagina	/open-h2020/projects/208512/index.html
-1	/open-h2020/per-country/it/agenzia+napoletana+per+l'energia+e+per+l'ambiente/index.html
-2	/open-h2020/per-country/be/centre+de+recherche+en+aeronautique+asbl+-+cenaero/index.html

Opendata, web and dolomites

RapidDiag

Development of a compatible nanoparticle based rapid and sensitive diagnostic platform for microbial infections

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

RapidDiag project word cloud

Explore the words cloud of the RapidDiag project. It provides you a very rough idea of what is the project "RapidDiag" about.

diagnostic written resistance nanodrugs treat 2 remaining prescriptions participation biowise drug company effectiveness losing deaths specialises healthcare instrumentation majority antibiotics training play financial medical waste minimal rapid generation ltd suffering conferences alone leads give kit viral diagnosis diseases save mentoring antibiotic infection needless pathogens 12 helping 16 scheme reductions mortality repeated trend resistant infections millions associate leaders morbidity patients patient industrial rate diagnose global symptoms innovation euros strains correctly lig sme prescription million bacterial staff worldwide attend technologically bacteria full expensive incorrectly ing difficult academic core investigation infectious uk nanodiagnostic

Project "RapidDiag" data sheet

The following table provides information about the project.

Coordinator	LIG BIOWISE LIMITED Organization address address: APARTMENT 13 QUEENS COLLEGE CHAMBERS 38 PARADISE ST city: BIRMINGHAM postcode: B1 2AF website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	United Kingdom [UK]
Project website	http://www.lig-biowise.com
Total cost	70˙187 €
EC max contribution	70˙187 € (100%)
Programme	1. H2020-EU.2.3.2.2. (Enhancing the innovation capacity of SMEs)
Code Call	H2020-INNOSUP-02-2016
Funding Scheme	CSA
Starting year	2017
Duration (year-month-day)	from 2017-09-01 to 2018-08-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	LIG BIOWISE LIMITED LIG BIOWISE LIMITED Organization address address: APARTMENT 13 QUEENS COLLEGE CHAMBERS 38 PARADISE ST city: BIRMINGHAM postcode: B1 2AF website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (BIRMINGHAM)	coordinator	70˙187.00

Map

Project objective

LIG Biowise Ltd specialises in the development of targeted nanodrugs and targeted nanodiagnostic systems. The company is now developing a next generation rapid diagnostic system for use by healthcare staff to quickly determine whether medical symptoms are a viral infection or bacterial infection. Many infectious diseases present with similar symptoms and it can be difficult to correctly diagnose and treat a patient without further diagnostic investigation.

Infectious diseases are one of the major cases of global morbidity and mortality, resulting in 16.2% of all deaths per year. The majority of these infectious diseases are a result of viral or bacterial pathogens. It is estimated that in the UK alone, over 10 million needless antibiotic prescriptions are written each year. This number includes prescriptions incorrectly given to patients suffering from viral infections. This is not only a waste of financial resources, but also leads to the development of drug resistant bacteria strains. This trend has been repeated worldwide, meaning that antibiotics are losing their effectiveness at an increasing rate and antibiotic resistance has become a worldwide problem. A diagnostic kit, such as the product proposed by LIG Biowise, will save millions of euros in costs associated with the over prescription of antibiotics for viral infections and lead to reductions in the number of drug resistant bacteria.

LIG Biowise’s rapid medical diagnostic kit will give healthcare staff a rapid diagnosis, while remaining technologically simple, have minimal training requirements and will not require expensive instrumentation. The SME Innovation Associate will play a crucial role in helping LIG Biowise reach this goal. They will also undertake a 12-month training programme, including; a mentoring scheme with academic and industrial leaders, opportunities to attend conferences, and full participation in EU core training programme.

Deliverables

List of deliverables.
Plan and deliver a series of presentations for seminars	Documents, reports	2019-05-28 09:59:31

Take a look to the deliverables list in detail: detailed list of RapidDiag deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "RAPIDDIAG" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "RAPIDDIAG" are provided by the European Opendata Portal: CORDIS opendata.